New Analyst Review, Aastrom Biosciences (ASTM)
November 11th, 2010
No comments
Scimitar Equity continues to rank ASTM with a BUY ranking and believe the current market pricing is finally actualizing the share price’s potential having previously valued it at $3.69 Read more…
